- Home
- » Tags
- » Rogletimide
Top View
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- WO 2016/176208 Al 3 November 2016 (03.11.2016) P O P C T
- Università Degli Studi Di Padova Dipartimento Di Scienze Del Farmaco ______
- Letrozole Is Superior to Anastrozole in Suppressing Breast Cancer Tissue and Plasma Estrogen Levels Ju« Rgen Geisler,1Hilgegunn Helle,2 Dagfinn Ekse,2 Nhat K
- Harmonized Tariff Schedule of the United States (2006) (Rev
- The Influence of Aminoglutethimide and Its Analogue Rogletimide on Peripheral Aromatisation in Breast Cancer
- Understanding Aromatase: a Mechanistic Basis For
- Downloaded from Bioscientifica.Com at 10/01/2021 01:49:57AM Via Free Access Review P E Lønning and Aromatase Inhibition 2013 20:4 R184 H P Eikesdal
- Aromatase Inhibitors As Potential Cancer Chemopreventives
- Cross-Resistance to Different Aromatase Inhibitors in Breast Cancer Treatment
- Compositions for Treating Breast Cancer
- 35 U.S.C. § 156 For: Inhibitors of Bruton's Tyrosine Kinase
- Breast Cancer
- Refined Preparation of 1α,3-Dipyrrolidino-Androsta-3,5
- (12) United States Patent (10) Patent No.: US 8,968,730 B2 Koenig Et Al
- Aromatase Inhibitors in the Breast Cancer Clinic: Focus on Exemestane
- Drug and Hormone Interactions of Aromatase Inhibitors
- 2U11/135459 A2
- WO 2013/138666 Al I
- Aromatase Inhibitors in the Breast Cancer Clinic: Focus on Exemestane
- Characterization of Androgenic and Estrogenic Responses in the Rainbow Trout by Comparing Liver Slice to Whole Animal Studies
- (12) United States Patent (10) Patent No.: US 9,181,257 B2 Honigberg Et Al
- The Potential for Aromatase Inhibition in Breast Cancer Prevention